Guangzhou Wondfo Biotech Co.,Ltd
SHZ: 300482.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Zhongxiong Peng
- Employees
- 3,197
- Headquarters
- Guangzhou, China
- IPO year
- 2015
- Market cap
- CN¥9.0B
- Website
- https://www.wondfo.com.cn
Loading 300482…
Loading profile data…Frequently asked questions about 300482
What does Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ) do?
Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as...
Where does 300482.SZ trade?
Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300482.SZ in?
Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Guangzhou Wondfo Biotech Co.,Ltd?
Zhongxiong Peng is the chief executive officer of Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ).
Where is Guangzhou Wondfo Biotech Co.,Ltd headquartered?
Guangzhou Wondfo Biotech Co.,Ltd is headquartered in China.
Does 300482.SZ pay a dividend?
Yes — Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ) paid a trailing twelve-month dividend of CNY 0.40 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300482.SZ go public?
Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ) completed its initial public offering in 2015.